Gemcitabine/Vinorelbine in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines: Results of a Phase II Trial

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Phase II Trial of Gemcitabine plus Trastuzumab in Metastatic Breast Cancer Patients Previously Treated with Chemotherapy: Preliminary Results

Clinical Breast Cancer ◽

10.3816/cbc.2002.s.004 ◽

2002 ◽

Vol 3 ◽

pp. S17-S20 ◽

Cited By ~ 40

Author(s):

Joyce O'Shaughnessy ◽

Svetislava J. Vukelja ◽

Thomas Marsland ◽

Gary Kimmel ◽

Suresh Ratnam ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Preliminary Results ◽

Three-Year Follow-Up of Survival and Progression in a Phase II Trial of Gemcitabine Plus Carboplatin (Plus Trastuzumab in HER2+ Patients) in Metastatic Breast Cancer Patients.

10.1158/0008-5472.sabcs-09-2105 ◽

2009 ◽

Author(s):

D. Loesch ◽

L. Asmar ◽

K. McIntyre ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Abstract OT2-09-01: A multicenter, randomized, phase II trial evaluating the efficacy of eribulin monotherapy and eribulin plus endocrine therapy in locally-recurrent or metastatic breast cancer patients after progression on endocrine therapy (REVERT study)

10.1158/1538-7445.sabcs19-ot2-09-01 ◽

2020 ◽

Author(s):

José Manuel Pérez-García ◽

Alfonso Cortés Salgado ◽

Elena López Miranda ◽

Antonio Antón ◽

Pedro Sánchez Rovira ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Locally Recurrent

Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: A phase II study

Medical and Pediatric Oncology ◽

10.1002/(sici)1096-911x(200001)34:1<10::aid-mpo2>3.0.co;2-a ◽

2000 ◽

Vol 34 (1) ◽

pp. 10-13 ◽

Cited By ~ 4

Author(s):

Getta Fried ◽

Moshe E. Stein ◽

Nissim Haim

Keyword(s):

Breast Cancer ◽

Oral Administration ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Clinical Activity ◽

Breast Cancer Patients ◽

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1570-7 ◽

2011 ◽

Vol 68 (4) ◽

pp. 1009-1016 ◽

Cited By ~ 2

Author(s):

R. Murialdo ◽

F. Bertolotti ◽

G. Pastorino ◽

M. Mencoboni ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Her 2

Phase II Study of Oral 4-Demethoxydaunorubicin in Previously Treated (Except Anthracyclines) Metastatic Breast Cancer Patients

Oncology ◽

10.1159/000226450 ◽

1987 ◽

Vol 44 (2) ◽

pp. 82-86 ◽

Cited By ~ 9

Author(s):

K. Kolarić ◽

Z. Mechl ◽

V. Potrebica ◽

B. Šopkova

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Faculty of 1000 evaluation for Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718071081.793483707 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

PLoS ONE ◽

10.1371/journal.pone.0069256 ◽

2013 ◽

Vol 8 (7) ◽

pp. e69256 ◽

Cited By ~ 8

Author(s):

George Fountzilas ◽

Vassiliki Kotoula ◽

Dimitrios Pectasides ◽

George Kouvatseas ◽

Eleni Timotheadou ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e3182005783 ◽

2012 ◽

Vol 35 (1) ◽

pp. 18-21 ◽

Cited By ~ 11

Author(s):

Jean-Philippe Jacquin ◽

Cyrus Chargari ◽

Julie Thorin ◽

Dominique Mille ◽

Adrien Mélis ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06292-7 ◽

2021 ◽

Vol 189 (3) ◽

pp. 641-651

Author(s):

Jing Xu ◽

Tanya E. Keenan ◽

Beth Overmoyer ◽

Nadine M. Tung ◽

Rebecca S. Gelman ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽